ANCONA, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 409
EU - Europa 112
AS - Asia 56
SA - Sud America 2
Totale 579
Nazione #
US - Stati Uniti d'America 405
IT - Italia 50
CN - Cina 33
DE - Germania 10
GB - Regno Unito 10
IE - Irlanda 10
RU - Federazione Russa 9
BE - Belgio 8
IN - India 8
SG - Singapore 8
CA - Canada 3
FI - Finlandia 3
FR - Francia 3
TR - Turchia 3
UA - Ucraina 3
BR - Brasile 2
IR - Iran 2
PL - Polonia 2
SE - Svezia 2
HK - Hong Kong 1
MT - Malta 1
MX - Messico 1
NL - Olanda 1
PH - Filippine 1
Totale 579
Città #
Fairfield 61
Chandler 50
Woodbridge 33
Ann Arbor 32
Ashburn 32
Wilmington 32
Houston 21
Seattle 21
Des Moines 16
Palermo 16
Cambridge 14
Dublin 10
Medford 10
Brussels 8
Singapore 8
Altamura 7
Beijing 7
Nanjing 7
Lawrence 6
Princeton 6
San Diego 6
Boardman 5
Kochi 5
Redwood City 5
Hebei 4
Ankara 3
Jinan 3
London 3
Ludwigshafen am Rhein 3
New York 3
Atlanta 2
Chicago 2
Frankfurt am Main 2
Guangzhou 2
Helsinki 2
Jacksonville 2
Los Angeles 2
Melfi 2
Ottawa 2
Shenyang 2
Stockholm 2
Agrate Conturbia 1
Amsterdam 1
Bari 1
Castellana Grotte 1
Castelnuovo Rangone 1
Central District 1
Changsha 1
Clearwater 1
Dearborn 1
Duncan 1
Hangzhou 1
Hyderabad 1
Il-Madliena 1
Kashan 1
Kitzingen 1
Kumar 1
Leawood 1
Lucca 1
Macaé 1
Milan 1
Nanchang 1
Nürnberg 1
Orange 1
Phoenix 1
Pullach 1
Pune 1
Saint Petersburg 1
San Francisco 1
San Paolo di Civitate 1
São Paulo 1
Taizhou 1
Tianjin 1
Toronto 1
Venice 1
Washington 1
Zhengzhou 1
Totale 495
Nome #
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy 170
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report 141
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 100
Gastric metastasis from breast cancer 86
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 70
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 60
null 3
Totale 630
Categoria #
all - tutte 2.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020140 14 6 4 30 13 13 13 10 14 7 13 3
2020/2021124 4 7 3 26 9 8 6 7 14 18 15 7
2021/202271 2 14 0 3 7 4 5 1 10 7 4 14
2022/2023150 14 28 2 22 13 29 12 8 12 1 4 5
2023/202453 3 4 2 4 1 11 4 4 0 5 4 11
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 630